March 25, 2020 / 10:50 AM / 14 days ago

BRIEF-Scandion Oncology: SCO-101 Works In Synergy With The Chemotherapy Drug Docetaxel In Drug Resistant Cancer Cells

March 25 (Reuters) - Scandion Oncology A/S:

* SCO-101 WORKS IN SYNERGY WITH THE CHEMOTHERAPY DRUG DOCETAXEL IN DRUG RESISTANT CANCER CELLS

* SCO-101 SIGNIFICANTLY INCREASES POTENCY OF DOCETAXEL Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below